- Home
- BMRN vs COKE Comparison
BMRN vs COKE Comparison
Compare BMRN & COKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BMRN | COKE |
|---|---|---|
| Founded | 1996 | 1902 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Beverages (Production/Distribution) |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.3B | 13.3B |
| IPO Year | 1999 | 1994 |
Fundamental Metrics
Financial Performance| Metric | BMRN | COKE |
|---|---|---|
| Price | $56.34 | $213.67 |
| Analyst Decision | Buy | |
| Analyst Count | 28 | 0 |
| Target Price | ★ $91.59 | N/A |
| AVG Volume (30 Days) | ★ 2.1M | 380.7K |
| Earning Date | 10-30-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 0.48% |
| EPS Growth | N/A | ★ 156.81 |
| EPS | 0.77 | ★ 1.21 |
| Revenue | $1,313,646,000.00 | ★ $7,228,055,000.00 |
| Revenue This Year | $21.42 | N/A |
| Revenue Next Year | $14.51 | N/A |
| P/E Ratio | ★ $70.97 | $175.53 |
| Revenue Growth | ★ 17.62 | 4.76 |
| 52 Week Low | $49.26 | $126.00 |
| 52 Week High | $70.98 | $218.73 |
Technical Indicators
Market Signals| Indicator | BMRN | COKE |
|---|---|---|
| Relative Strength Index (RSI) | 31.35 | 68.95 |
| Support Level | $53.61 | $184.30 |
| Resistance Level | $57.95 | $218.64 |
| Average True Range (ATR) | 1.42 | 5.81 |
| MACD | -0.06 | 2.11 |
| Stochastic Oscillator | 11.06 | 97.18 |
Price Performance
Historical ComparisonAbout BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About COKE Coca-Cola Consolidated Inc.
Coca-Cola Consolidated Inc distributes, markets, and manufactures nonalcoholic beverages. It offers a range of nonalcoholic beverage products and flavors, including both sparkling and still beverages. Sparkling beverages are carbonated beverages, and the Company's principal sparkling beverage is Coca-Cola. Still beverages include energy products and non-carbonated beverages such as bottled water, ready-to-drink tea, ready-to-drink coffee, enhanced water, juices, and sports drinks. The Company has two operating segments: Nonalcoholic Beverages and All Other. Key revenue is generated from Nonalcoholic Beverages.